Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1221

1.

Characteristic fast H- ion conduction in oxygen-substituted lanthanum hydride.

Fukui K, Iimura S, Tada T, Fujitsu S, Sasase M, Tamatsukuri H, Honda T, Ikeda K, Otomo T, Hosono H.

Nat Commun. 2019 Jun 12;10(1):2578. doi: 10.1038/s41467-019-10492-7.

PMID:
31189877
2.

The course of elderly patients with persistent hepatitis C virus infection without hepatocellular carcinoma.

Mizuno K, Toyoda H, Yasuda S, Tada T, Kumada T, Sone Y, Tanaka J.

J Gastroenterol. 2019 Jun 3. doi: 10.1007/s00535-019-01595-5. [Epub ahead of print]

PMID:
31161311
3.

Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism - From the COMMAND VTE Registry.

Yoshikawa Y, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Circ J. 2019 May 28. doi: 10.1253/circj.CJ-19-0229. [Epub ahead of print]

4.

Emergence of carbapenem-resistant Pseudomonas asiatica producing NDM-1 and VIM-2 metallo-β-lactamases in Myanmar.

Tohya M, Tada T, Watanabe S, Kuwahara-Arai K, Zin KN, Zaw NN, Aung MY, Mya S, Zan KN, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00475-19. doi: 10.1128/AAC.00475-19. [Epub ahead of print]

PMID:
31138570
5.

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Cancer Med. 2019 May 24. doi: 10.1002/cam4.2241. [Epub ahead of print]

6.

Trends and Efficacy of Interferon-Free Anti-hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.

Toyoda H, Atsukawa M, Uojima H, Nozaki A, Tamai H, Takaguchi K, Fujioka S, Nakamuta M, Tada T, Yasuda S, Chuma M, Senoh T, Tsutsui A, Yamashita N, Hiraoka A, Michitaka K, Shima T, Akahane T, Itobayashi E, Watanabe T, Ikeda H, Iio E, Fukunishi S, Asano T, Tachi Y, Ikegami T, Tsuji K, Abe H, Kato K, Mikami S, Okubo H, Shimada N, Ishikawa T, Matsumoto Y, Itokawa N, Arai T, Tsubota A, Iwakiri K, Tanaka Y, Kumada T.

Open Forum Infect Dis. 2019 Apr 15;6(5):ofz185. doi: 10.1093/ofid/ofz185. eCollection 2019 May.

7.

Discovery of hexagonal ternary phase Ti2InB2 and its evolution to layered boride TiB.

Wang J, Ye TN, Gong Y, Wu J, Miao N, Tada T, Hosono H.

Nat Commun. 2019 May 23;10(1):2284. doi: 10.1038/s41467-019-10297-8.

8.

Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease.

Tada T, Toyoda H, Sone Y, Yasuda S, Miyake N, Kumada T, Tanaka J.

J Gastroenterol Hepatol. 2019 May 21. doi: 10.1111/jgh.14734. [Epub ahead of print]

PMID:
31115065
9.

Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model.

Tada T, Toyoda H, Yasuda S, Miyake N, Kumada T, Kurisu A, Ohisa M, Akita T, Tanaka J.

Eur J Gastroenterol Hepatol. 2019 May 6. doi: 10.1097/MEG.0000000000001434. [Epub ahead of print]

PMID:
31082998
10.

Classification for invasion depth of esophageal squamous cell carcinoma using a deep neural network compared with experienced endoscopists.

Nakagawa K, Ishihara R, Aoyama K, Ohmori M, Nakahira H, Matsuura N, Shichijo S, Nishida T, Yamada T, Yamaguchi S, Ogiyama H, Egawa S, Kishida O, Tada T.

Gastrointest Endosc. 2019 May 8. pii: S0016-5107(19)31675-X. doi: 10.1016/j.gie.2019.04.245. [Epub ahead of print]

PMID:
31077698
11.

Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Who Achieved Sustained Virologic Response.

Toyoda H, Tada T, Yasuda S, Mizuno K, Ito T, Kumada T.

Clin Infect Dis. 2019 May 6. pii: ciz359. doi: 10.1093/cid/ciz359. [Epub ahead of print]

PMID:
31056696
12.

Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis.

Hiraoka A, Kumada T, Tsuji K, Takaguchi K, Itobayashi E, Kariyama K, Ochi H, Tajiri K, Hirooka M, Shimada N, Ishikawa T, Tachi Y, Tada T, Toyoda H, Nouso K, Joko K, Hiasa Y, Michitaka K, Kudo M.

Liver Cancer. 2019 Mar;8(2):121-129. doi: 10.1159/000488778. Epub 2018 Jun 11.

13.

Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer.

Hayase S, Yamada L, Ujiie D, Nirei A, Tada T, Hanayama H, Monma T, Saze Z, Ohki S, Kono K.

Fukushima J Med Sci. 2019;65(1):6-12. doi: 10.5387/fms.2018-12.

14.

Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET.

Takahashi M, Tada T, Nakamura T, Koyama K, Momose T.

Am J Alzheimers Dis Other Demen. 2019 Apr 9:1533317519841192. doi: 10.1177/1533317519841192. [Epub ahead of print]

PMID:
30966759
15.

A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan.

Hishinuma T, Tada T, Uchida H, Shimojima M, Kirikae T.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00124-19. doi: 10.1128/AAC.00124-19. Print 2019 Jun.

PMID:
30962328
16.

Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice.

Norton TD, Zhen A, Tada T, Kim J, Kitchen S, Landau NR.

Mol Ther. 2019 May 8;27(5):960-973. doi: 10.1016/j.ymthe.2019.03.008. Epub 2019 Mar 15.

PMID:
30962161
17.

Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios.

Tada T, Kumada T, Toyoda H, Yasuda S, Koyabu T, Nakashima M.

Nutr Cancer. 2019 Apr 6:1-10. doi: 10.1080/01635581.2019.1597905. [Epub ahead of print]

PMID:
30955354
18.

Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onset - From the COMMAND VTE Registry.

Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators.

Circ J. 2019 May 24;83(6):1377-1384. doi: 10.1253/circj.CJ-18-1314. Epub 2019 Mar 30.

19.

Long-Term Outcomes of Drug-Eluting Stent Implantation After Rotational Atherectomy for Left Main Coronary Artery Bifurcation Lesions.

Fuku Y, Kadota K, Toyofuku M, Morimoto T, Ohya M, Higami H, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA Stenting Registry Investigators.

Am J Cardiol. 2019 Jun 1;123(11):1796-1805. doi: 10.1016/j.amjcard.2019.03.002. Epub 2019 Mar 9.

PMID:
30929770
20.

Cross-sectional and longitudinal relationship between physical fitness and academic achievement in Japanese adolescents.

Sasayama K, Nonoue K, Tada T, Adachi M.

Eur J Sport Sci. 2019 Mar 28:1-10. doi: 10.1080/17461391.2019.1593509. [Epub ahead of print]

PMID:
30922177

Supplemental Content

Loading ...
Support Center